VCAM1 and acute respiratory distress syndrome: VCAM-1 expression is raised in acute respiratory distress syndrome [48], in breast [49] and non-small cell lung cancer [50], and in rheumatoid arthritis [51], where it decreases following treatment with infliximab and methotrexate [52].